๎๊ฒ์
๎๊ฒ์
๎
Emergent BioSolutions Inc
EBS๎ญ๊ด์ฌ ๋ชฉ๋ก์ ์ถ๊ฐ
8.130USD
+0.190+2.39%
์ข
๊ฐย 05/18, 16:00๏ผET๏ผ์์ธ๋ 15๋ถ ์ง์ฐ๋ฉ๋๋ค
421.13M์๊ฐ์ด์ก
์์คP/E TTM
๎
์์ธํ ๋ด์ฉ์ Emergent BioSolutions Inc ํ์ฌ
Emergent BioSolutions, Inc. is a life sciences company. It is focused on providing preparedness and response solutions addressing accidental, deliberate and naturally occurring public health threats. Its solutions include a product portfolio, a product development portfolio, and a contract development and manufacturing services portfolio. Its segments include Commercial Products, MCM Products, and Services segment. Its Commercial Product segment consists of NARCAN Nasal Spray. Its MCM Products segment consists of Anthrax MCM products, Smallpox MCM products and Other Products. Its Services segment consists of its Bioservices portfolio. NARCAN (naloxone HCl) Nasal Spray, an intranasal formulation of naloxone, is developed for the emergency treatment of known or suspected opioid overdose as manifested by respiratory and central nervous system depression. Its Bioservices consist of development services, bulk drug substance manufacturing, fill, finish, and packaging of final drug products.
Emergent BioSolutions Inc ์ ๋ณด
๎์ข
๋ชฉ ์ฝ๋ EBS
ํ์ฌ ์ด๋ฆEmergent BioSolutions Inc
์์ฅ์ผNov 15, 2006
CEOPapa (Joseph C)
์ง์ ์900
์ ํOrdinary Share
ํ๊ณ ์ฐ๋ ์ข
๋ฃNov 15
์ฃผ์300 Professional Dr
๋์GAITHERSBURG
์ฆ๊ถ ๊ฑฐ๋์NASDAQ OMX NASDAQ Basic NYSE
๊ตญ๊ฐUnited States of America
์ฐํธ ๋ฒํธ20879
์ ํ12406313200
์น์ฌ์ดํธhttps://emergentbiosolutions.com/
์ข
๋ชฉ ์ฝ๋ EBS
์์ฅ์ผNov 15, 2006
CEOPapa (Joseph C)
Emergent BioSolutions Inc์ ํ์ฌ ์์์ง
๎์ด๋ฆ
์ด๋ฆ/์ง์
์ง์
์ฃผ์ ๋ณด์
๋ณ๋
Mr. Joseph C. (Joe) Papa
Mr. Joseph C. (Joe) Papa
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
304.82K
+61.58%
Mr. Richard S. (Rich) Lindahl
Mr. Richard S. (Rich) Lindahl
Chief Financial Officer, Executive Vice President, Treasurer
Chief Financial Officer, Executive Vice President, Treasurer
271.92K
+59.83%
Ms. Jessica Perl
Ms. Jessica Perl
Senior Vice President, General Counsel, Corporate Secretary
Senior Vice President, General Counsel, Corporate Secretary
165.29K
+63.09%
Ms. Coleen Glessner
Ms. Coleen Glessner
Executive Vice President - Quality and Ethics and Compliance
Executive Vice President - Quality and Ethics and Compliance
155.93K
+64.20%
Mr. William Hartzel
Mr. William Hartzel
Senior Vice President - Manufacturing and Bioservices
Senior Vice President - Manufacturing and Bioservices
146.77K
+68.21%
Dr. Simon C Lowry, M.D.
Dr. Simon C Lowry, M.D.
Chief Medical Officer, Head of Research and Development
Chief Medical Officer, Head of Research and Development
116.59K
+85.86%
Dr. Zsolt Harsanyi, Ph.D.
Dr. Zsolt Harsanyi, Ph.D.
Independent Chairman of the Board
Independent Chairman of the Board
114.67K
+22.10%
Mr. Ronald B. Richard
Mr. Ronald B. Richard
Independent Director
Independent Director
89.36K
+28.36%
Mr. Marvin L. White
Mr. Marvin L. White
Independent Director
Independent Director
79.44K
+31.90%
Mr. Keith A. Katkin, CPA
Mr. Keith A. Katkin, CPA
Independent Director
Independent Director
59.03K
+16.71%
๋ ๋ณด๊ธฐ
์ด๋ฆ
์ด๋ฆ/์ง์
์ง์
์ฃผ์ ๋ณด์
๋ณ๋
Mr. Joseph C. (Joe) Papa
Mr. Joseph C. (Joe) Papa
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
304.82K
+61.58%
Mr. Richard S. (Rich) Lindahl
Mr. Richard S. (Rich) Lindahl
Chief Financial Officer, Executive Vice President, Treasurer
Chief Financial Officer, Executive Vice President, Treasurer
271.92K
+59.83%
Ms. Jessica Perl
Ms. Jessica Perl
Senior Vice President, General Counsel, Corporate Secretary
Senior Vice President, General Counsel, Corporate Secretary
165.29K
+63.09%
Ms. Coleen Glessner
Ms. Coleen Glessner
Executive Vice President - Quality and Ethics and Compliance
Executive Vice President - Quality and Ethics and Compliance
155.93K
+64.20%
Mr. William Hartzel
Mr. William Hartzel
Senior Vice President - Manufacturing and Bioservices
Senior Vice President - Manufacturing and Bioservices
146.77K
+68.21%
Dr. Simon C Lowry, M.D.
Dr. Simon C Lowry, M.D.
Chief Medical Officer, Head of Research and Development
Chief Medical Officer, Head of Research and Development
116.59K
+85.86%
์์ต ๋ถ์
ํตํ: USD๋ง์ง๋ง ์
๋ฐ์ดํธ: Mon, Apr 6
ํตํ: USD๋ง์ง๋ง ์
๋ฐ์ดํธ: Mon, Apr 6
FY2025
FY2025Q4
FY2025Q3
FY2025Q2
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2021
FY2020
FY2019
์ฌ์
๋ณUSD
์ด๋ฆ
์์ต
๋น์จ
Commercial Product sales
223.30M
30.06%
MCM Product sales
156.50M
21.07%
Contracts and grants
36.70M
4.94%
Bioservices
23.40M
3.15%
์ง์ญ๋ณUSD
์ด๋ฆ
์์ต
๋น์จ
Non-U.S Government
403.20M
54.27%
U.S.Government
36.70M
4.94%
์ฌ์
๋ณ
์ง์ญ๋ณ
์ฌ์
๋ณUSD
์ด๋ฆ
์์ต
๋น์จ
Commercial Product sales
223.30M
30.06%
MCM Product sales
156.50M
21.07%
Contracts and grants
36.70M
4.94%
Bioservices
23.40M
3.15%
์ฃผ์ ๋ณด์ ํต๊ณ
๋ง์ง๋ง ์
๋ฐ์ดํธ: Sun, May 10
๋ง์ง๋ง ์
๋ฐ์ดํธ: Sun, May 10
์ฃผ์ฃผ
์ฃผ์ฃผ ์ ํ
์ฃผ์ฃผ
์ฃผ์ฃผ
๋น์จ
BlackRock Institutional Trust Company, N.A.
7.60%
Dimensional Fund Advisors, L.P.
5.34%
State Street Investment Management (US)
5.23%
American Century Investment Management, Inc.
4.73%
Vanguard Capital Management, LLC
4.38%
๊ธฐํ
72.72%
์ฃผ์ฃผ
์ฃผ์ฃผ
๋น์จ
BlackRock Institutional Trust Company, N.A.
7.60%
Dimensional Fund Advisors, L.P.
5.34%
State Street Investment Management (US)
5.23%
American Century Investment Management, Inc.
4.73%
Vanguard Capital Management, LLC
4.38%
๊ธฐํ
72.72%
์ฃผ์ฃผ ์ ํ
์ฃผ์ฃผ
๋น์จ
Investment Advisor
37.35%
Investment Advisor/Hedge Fund
31.07%
Hedge Fund
8.77%
Research Firm
3.93%
Individual Investor
3.86%
Pension Fund
1.01%
Bank and Trust
0.36%
Family Office
0.06%
Insurance Company
0.02%
๊ธฐํ
13.55%
๊ธฐ๊ด ์ฃผ์ ๋ณด์
๎๋ง์ง๋ง ์
๋ฐ์ดํธ: Wed, Apr 1
๋ง์ง๋ง ์
๋ฐ์ดํธ: Wed, Apr 1
๋ณด๊ณ ๊ธฐ๊ฐ
๊ธฐ๊ด ์
๋ณด์ ์ฃผ์
๋น์จ
๋ณ๋
2026Q1
412
42.30M
81.98%
-3.37M
2025Q4
378
39.86M
83.14%
+128.30K
2025Q3
417
39.73M
84.87%
+2.04M
2025Q2
439
37.58M
87.40%
+1.14M
2025Q1
454
36.44M
84.55%
-9.64M
2024Q4
461
35.04M
82.31%
+2.84M
2024Q3
467
32.21M
81.37%
+1.29M
2024Q2
485
30.86M
99.60%
-5.54M
2024Q1
494
36.44M
103.37%
-17.72M
2023Q4
512
41.89M
103.68%
-1.06M
๋ ๋ณด๊ธฐ
์ฃผ์ฃผ ํ๋
๎์ด๋ฆ
๋ณด์ ์ฃผ์
๋น์จ
๋ณ๋
Chg %
๋ ์ง
BlackRock Institutional Trust Company, N.A.
3.92M
7.6%
+17.75K
+0.45%
Dec 31, 2025
Dimensional Fund Advisors, L.P.
2.25M
4.36%
+112.27K
+5.25%
Dec 31, 2025
State Street Investment Management (US)
2.70M
5.22%
+250.62K
+10.25%
Dec 31, 2025
American Century Investment Management, Inc.
2.44M
4.72%
+57.06K
+2.40%
Dec 31, 2025
Charles Schwab Investment Management, Inc.
1.62M
3.13%
+237.15K
+17.16%
Dec 31, 2025
Palisade Capital Management, LLC
1.27M
2.45%
-160.25K
-11.24%
Dec 31, 2025
Geode Capital Management, L.L.C.
1.25M
2.42%
-28.68K
-2.24%
Dec 31, 2025
Oak Hill Advisors, L.P.
1.11M
2.16%
--
--
Dec 31, 2025
๋ ๋ณด๊ธฐ
๊ด๋ จ ETF
๎๋ง์ง๋ง ์
๋ฐ์ดํธ: Sat, Dec 6
๋ง์ง๋ง ์
๋ฐ์ดํธ: Sat, Dec 6
์ด๋ฆ
๋น์จ
AdvisorShares Insider Advantage ETF
0.97%
Royce Quant Small-Cap Quality Value ETF
0.41%
State Street SPDR S&P Biotech ETF
0.28%
Federated Hermes MDT Small Cap Core ETF
0.23%
Harbor Human Capital Factor US Small Cap ETF
0.19%
Direxion Daily S&P Biotech Bull 3X Shares
0.18%
Pacer US Small Cap Cash Cows ETF
0.16%
Invesco RAFI US 1500 Small-Mid ETF
0.15%
Avantis US Small Cap Value ETF
0.14%
iShares Micro-Cap ETF
0.13%
๋ ๋ณด๊ธฐ
AdvisorShares Insider Advantage ETF
๋น์จ0.97%
Royce Quant Small-Cap Quality Value ETF
๋น์จ0.41%
State Street SPDR S&P Biotech ETF
๋น์จ0.28%
Federated Hermes MDT Small Cap Core ETF
๋น์จ0.23%
Harbor Human Capital Factor US Small Cap ETF
๋น์จ0.19%
Direxion Daily S&P Biotech Bull 3X Shares
๋น์จ0.18%
Pacer US Small Cap Cash Cows ETF
๋น์จ0.16%
Invesco RAFI US 1500 Small-Mid ETF
๋น์จ0.15%
Avantis US Small Cap Value ETF
๋น์จ0.14%
iShares Micro-Cap ETF
๋น์จ0.13%
์ฃผ์ ๋ฐฐ๋น๊ธ
๎์ง๋ 5๋
๋์ ์ด
0.00
USD์ ๋ฐฐ๋น๊ธ์ด ๋ถ๋ฐฐ๋์์ต๋๋ค.
๋ ์ง
๋ฐฐ๋น๊ธ
๊ธฐ์ค์ผ
์ง๊ธ์ผ
๋ฐฐ๋น๋ฝ์ผ
๋ฐ์ดํฐ ์์
์ฃผ์ ๋ถํ
๎๋ ์ง
๋ฐฐ๋น๋ฝ์ผ
์ ํ
๋น์จ
๋ฐ์ดํฐ ์์
๋ ์ง
๋ฐฐ๋น๋ฝ์ผ
์ ํ
๋น์จ
๋ฐ์ดํฐ ์์
